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METHOD AND SYSTEM FOR

NON - INVASIVE OPTICAL BLOOD GLUCOSE
DETECTION UTILIZING SPECTRAL DATA

ANALYSIS
CROSS -REFERENCE TO RELATED

form SMBG more frequently and have improved quality of
life with a non - invasive blood glucose monitoring device .
There exist a number of non - invasive approaches for

5 blood glucose determination . One technique of non-invasive

APPLICATION

blood chemical detection involves collecting and analyzing
light spectra data .

Extracting information about blood characteristics, such
application Ser. No. 12 /425 ,535 , filed Apr. 17 , 2009, which 10 from spectroscopy, is a complex problem due to the presence
This application is a divisional of prior U . S . patent

as glucose concentration from spectral or other data obtained

is hereby incorporated herein by reference in its entirety , and
also claims priority to U .S . Provisional Patent Application

of components (e . g ., skin , fat, muscle , bone, interstitial
fluid ) other than blood in the area that is being sensed . Such

Ser. No. 61/ 055, 303 , filed on May 22 , 2008 , the disclosure

other components can influence these signals in such a way

ofwhich is incorporated herein by reference, and also claims as to alter the reading. In particular, the resulting signal may
priority to U . S . Provisional Patent Application Ser. No . 15 be much larger in magnitude than the portion of the signal
61/089 , 152 , filed on Aug . 15 , 2008 , the disclosure of which
that corresponds to blood , and therefore limits the ability to
is incorporated herein by reference .
accurately extract blood characteristics information .
The present invention is directed to overcoming one or
BACKGROUND OF THE INVENTION
more of the problems set forth above .
20
Diabetes is a chronic disease that , when not controlled ,
SUMMARY OF INVENTION
over time leads to serious damage to many of the body 's
systems, including the nerves, blood vessels, eyes, kidneys
In an aspect of the present invention , a system for

and heart. The National Institute of Diabetes and Digestive
detecting glucose in a biological sample is disclosed . This
and Kidney Diseases (NIDDK ) estimates that 23 .6 million 25 system includes at least one light source configured to strike
people , or 7 . 8 percent of the population in the United States,
a target area of a sample , at least one light detector posi
had diabetes in 2007. Globally, the World Health Organiza - tioned to receive light from the at least one light source and
tion (WHO ) estimates that more than 180 million people
to generate an output signal, having a time dependent
have diabetes, a number they expect to increase to 366
current, which is indicative of the power of light detected ,

million by 2030 , with 30 .3 million in the United States . 30 and a processor configured to receive the output signal from
According to the WHO , an estimated 1 . 1 million people died
from diabetes in 2005 . They project that diabetes deaths will
increase by more than 50 % between 2006 and 2015 overall

the at least one light detector and based on the received
output signal, calculate the attenuance attributable to blood
in a sample present in the target area and eliminate effect of

and by more than 80 % in upper-middle income countries .

uncertainty caused by temperature dependent detector

Diabetes Association , the total annual economic cost of

ciated with a sample present in the target area .

This 32 % increase means the dollar amount has risen over 40
A vital element of diabetes management is the selfmonitoring of blood glucose ( SMBG ) concentration by
diabetics in the home environment. By testing blood glucose
levels often , diabetics can better manage medication , diet, 45
and exercise to maintain control and prevent the long -term
negative health outcomes . In fact, the Diabetes Control and

method includes utilizing at least one light source configured
to strike a target area of a sample, utilizing at least one light
detector positioned to receive light from the at least one light
source and to generate an output signal, having a time
dependent current, which is indicative of the power of light
detected , and utilizing a processor that receives the output
signal from the at least one light detector and based on the
received output signal, calculating the attenuance attribut

only one- fourth as many people develop diabetic eye dis
ease, half as many develop kidney disease, one-third as

glucose level associated with a sample present in the target
area .

The economic burden from diabetes for individuals and 35 response of the at least one light detector, and based on the
society as a whole is substantial. According to the American
calculated attenuance , determine a blood glucose level asso

diabetes was estimated to be $ 174 billion in the United
States in 2007. This is an increase of $ 42 billion since 2002.
$ 8 billion more each year .

In yet another aspect of the present invention , a method
for detecting glucose in a biological sample is disclosed . The

Complications Trial (DCCT), which followed 1 ,441 diabetable to blood in a sample present in the target area and
ics for several years , showed that those following an inten eliminating effect of uncertainty caused by temperature
sive -control program with multiple blood sugar tests each 50 dependentdetector response of the at least one light detector,
day , as compared with the standard -treatment group , had
and based on the calculated attenuance , determining a blood

many develop nerve disease, and far fewer people who

These are merely some of the innumerable aspects of the
listing of the innumerable aspects associated with the pres

already had early forms of these three complications got 55 present invention and should not be deemed an all- inclusive

worse .

However, currentmonitoring techniques discourage regu -

lar use due to the inconvenient and painful nature of drawing
blood through the skin prior to analysis , which causes many

diabetics to not be as diligent as they should be for good 60

blood glucose control. As a result, non - invasive measure

ment of glucose concentration is a desirable and beneficial
development for the management of diabetes . A non - inva sive monitor will make testing multiple times each day

ent invention .
BRIEF DESCRIPTION OF THE DRAWINGS
For a better understanding of the present invention , ref

erence may be made to accompanying drawings , in which :
FIG . 1 illustrates a plot of a pulse wave corresponding to
light absorption of arterial blood, according to exemplary

pain -free and more palatable for children with diabetes . 65 embodiments ;
According to a study published in 2005 (I. Wagner, C .
FIG . 2 illustrates an exemplary system for obtaining
Malchoff, and G . Abbott , Diabetes Technology & Therapeu - spectral data ;
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FIG . 3 illustrates a plot of A (t), calculated according to
FIG . 4 is a basic illustrative schematic of a preamplifier
circuit that converts photocurrent into voltage prior to digi

Assuming that the peak of the cyclic photocurrent gen

erated by the light- sensing device is Ip , the adjacent valley

Equation ( 9 ) using data in FIG . 1; and

tization .

of the cyclic photocurrent is Iy, and the photocurrent gen
erated by the light-sensing device without a human finger is

5 1o , the transmittances corresponding to the peak and valley

photocurrents can be defined as:

DETAILED DESCRIPTION OF THE

INVENTION

In the following detailed description , numerous exem - 10

plary specific details are set forth in order to provide a

Ty =

and
and

thorough understanding ofthe invention. However, it willbe

understood by those skilled in the art that the present

invention may be practiced without these specific details, or
with various modifications of the details . In other instances, 15

well known methods , procedures , and components have not
been described in detail so as not to obscure the present
invention .
Optical spectroscopy can be used to determine the amount
of light absorbed and scattered , i.e., attenuated , by a bio - 20
logical sample such as a human finger. By measuring the
amount of light absorbed by the sample , it is possible to

determine glucose , cholesterol, and hemoglobin levels of a

Tp =
The corresponding peak and valley absorbance are :
Av= - log (Tv)
and

Ap= - log (Tp)
(4 )
The difference between Ay and A , represents the light

and scattering by the blood in
subject non -invasively . Fingertip measurements are usually absorption
ing
non
blood
constituents:
preferred because of the large concentration of capillaries in 25 "

the finger , exclud

the fingertip and because of the conversion of arterialblood
into venous blood that occurs in the fingertip . However, the
techniques of the present invention are not limited to use

AA = Ay – Ap

with a fingertip . For example , the biological sample could be
a human earlobe .

30

When light is transmitted through a biological sample ,
such as a human finger, the light is attenuated by various
components of the finger including skin , muscle , bone, fat ,
interstitial fluid and blood. It has been observed , however,

As can be seen in the algorithm shown in Equation (5 ) ,

require a determination of the current generated by the

cyclic pattern that corresponds to a heartbeat. It is believed

a sample is sufficient to calculate AA .

many other human body parts, the earlobe being one of
many examples.

apparatus for use in an exemplary embodiment. Optical

AA does not depend on 1o . Thus, calculating AA does not
light-sensing device without a sample . Monitoring the pho

that light attenuation by a human finger exhibits a small 35 tocurrent corresponding to light power transmitted through

that this cyclic pattern will be present in measurements of

FIG . 2 depicts a simplified block diagram of an exemplary

measurement system , which is generally indicated by
FIG . 1 depicts a plot 102 of a detector photocurrent, I (t), 40 numeral 200 , uses the “ pulsatile ” concept for determining an
that corresponds to the power of light received by a detector amount of light absorbed and scattered solely by the blood
after the light has passed through a subject's finger. As can in a sample (a human finger in this exemplary embodiment).
be seen , the detector photocurrent exhibits a cyclic pattern .
A power source 201 , such as a battery , provides power to a
This cyclic pattern is due to the subject's heartbeat, which light source 202 that generates a plurality of light beams
cyclically increases and decreases the quantity of blood in 45 204 , 206 , 208 , 210 that are directed toward the top of the
the subject' s capillaries ( or other structures ). Although the

finger of a subject. In an exemplary embodiment, each of the

magnitude of the cyclic pattern is small in comparison to the

light beams 204, 206 , 208 , 210 have the samewavelength or

total photocurrent generated by the detector, considerable
information can be extracted from the cyclic pattern of the

a different wavelength range , typically within 800 nm to
1600 nm . Although the optical measurement system 200 is

plot 102 . For example, assuming that the person 's heart rate 50 described herein as generating four (4 ) light beams, it is
is sixty beats per minute , the time between the start of any
pulse beat and the end of that pulse beat is one second

During this one-second period , the photocurrent will have a
maximum or peak reading 104 and minimum or valley

contemplated that the light source 202 can be altered to
generate fewer light beams or additional light beams in other

embodiments .
Aft
A first aperture 212 ensures that the light beams 204, 206 ,

reading 106 . The peak reading 104 of the plot corresponds 55 208 , 210 strike a target area of the finger. A second aperture
to when there is a minimum amount of blood in the

214 ensures that the portion of the light beams that are

capillaries, and the valley reading 106 corresponds to when

transmitted through the finger strike a lens 216 . Light beams

there is a maximum amount of blood in the capillaries . By
using information provided by the peak and valley of the

204 , 206 , 208 , 210 are attenuated by the finger and compo
nents of the optical measurement system 200 , and , thus,

finger constituents that are not in the capillaries, such as
skin , fat, bones , muscle and interstitial fluids, are excluded .
These major constituents that are not in the capillaries are
excluded because they are not likely to change during the

the finger. The attenuated light beams 218 , 220 , 222 , 224
strike the lens 216 , and the lens 216 collects the attenuated
light beams 218 , 220 , 222 , 224 so that they impinge more
efficiently on a detector block 226 .

cyclic plot, the optical absorption and scattering by major 60 attenuated light beams 218 , 220 , 222 , 224 are emitted from

time interval of one heartbeat. In other words, the light that 65

The detector block 226 is positioned directly under the

is absorbed and scattered , i. e ., attenuated , by the blood can

lens 216 and comprises a plurality of light- sensing devices

be detected based on the peaks and valleys of the plot 102.

(LSD ) 228 , 230 , 232 , 234 such as an array of photodiodes.
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According to one aspect of the opticalmeasurement system
dependent cyclic photocurrent Al(t), corresponding to the
200, each of the light-sensing devices 228 , 230 , 232, 234 heartbeat, a noise current n (t), and a constant baseline
detects a specific wavelength of light as defined by corre - photocurrent IB:
sponding interference filters (IF ) 236 , 238 , 240 , 242, respec
tively. The interference filter transmits one or more spectral 5
1o (t)=15 + A1(t)+n (t)
bands or lines of light , and blocks others .
The above Equation can be re -arranged as :
Each of the light- sensing devices 228 , 230 , 232 , 234
generates a corresponding photocurrent signal that is pro
portional to the power of the light received by the particular
Id (t)
Al(t) + n (t )
- = 1 +
13
light sensing device . The photocurrent signal generated by
the photodiode can be converted to another form of signal,
such as an analog voltage signal or a digital signal. A
Applying common logarithm to both side of the Equation
processor 243 is coupled to the detector block 226 and is
(
8
)
configured to calculate the change of photocurrent signals 15 . 1 ), one obtains:
244 , 246 , 248 , 250 .
According to one aspect, the processor 243 executes an
algorithm such as shown in the Equation (5 ) to calculate the

Ap)= log[- ]= log(1+ 960)+NO )

change in the light absorption (AA ) solely caused by the

blood in the finger. Thereafter, this quantitative calculation 20

of light absorption of the blood can be used to determine a
characteristic of the blood. For example , by comparing the
calculated light absorption value to predetermined values
corresponding to different glucose levels stored in a memory

FIG . 3 , which is generally indicated by numeral 300 ,
shows a typical A?t) plot 302, calculated according to
Equation (9 ) using data in FIG . 1 . For a pulse function A (t)
shown in FIG . 3, the following key relationship exists during

(not shown ), a blood - glucose level of the subject can be 25 the time interval of one heartbeat:
determined .
A difficulty associated with the finger based pulsatile
0 [A (0) ]= kAA

( 10 )

measurement devices . One solution involves data averaging.

(13)

detection methodology is low signal- to -noise (S /N ) ratio ,
because the amplitude of cyclic pattern (i.e., the differencece inin which
whi o [ A (t)] is the Standard Deviation of A (t), and k is
between peak and valley ) is typically 1 % - 2 % of the total 20 a proportional constant.
photocurrent generated by the light power transmitted
C onsidering the fact that Ip is a constant and o? (log IR ) = 0 ,
through the finger. To obtain a S /N ratio of 100 : 1 in the one obtains :
determination of AA , the baseline noise of the device being
(12)
used to measure the light absorption by the finger should not
0 [A (t) ]=o [log 1) (0)]
be larger than 3 . 0x10° in absorbance (peak to peak ), within 35 Therefore , the peak -to - valley height of the Aft) plot
a 10 Hz bandwidth .
during the time interval of one heartbeat can be obtained
However, a 3 .0x10 -5 absorbance (peak to peak ) baseline directly
from the standard deviation of the logarithm of
noise level within a 10 Hz bandwidth is difficult to obtain
Id
(
t
)
:
with the low light power levels that are used by some
battery - powered hand held non - invasive blood chemical 40
To increase the S /N ratio , the averaged value of AA , as

AA =

defined by the Equation below , is used in further calculation

to extract blood glucose concentration :

AA= Ž SA;

0 [ A (0) ] o [log /p ( )]
k

k

45 A major advantage of Equation (13 ) is that high S /N ratio

can be achieved within short data acquisition time (approxi

(6 )

In Equation (6 ), M is the number of heartbeats during the
time interval of the pulsatile measurement. However, this
approach requires long data acquisition time, due to the fact

mately one second ), as explained below .

In a finger based pulsatile measurement depicted by FIG .
2 , the value of the sum , Al(t)+ n (t) is typically less than 2 %
50 of te
the large
5001
lage constant
01154 baseline photocurrent IB . Therefore,

that the rate of heartbeat is in the order of one per second .

For example, 25 seconds would be needed for increasing the 55

Equation (9 ) can be approximated as:
A (t!) == 1091
log D13(t) ] . In 110 Al(t)lo+ n (t)

(14 )

S /N ratio by a factor of five, and 100 seconds would be

needed for increasing the S /N ratio by a factor of ten . In

comparison , current commercial blood drawing glucose

meters can determine blood glucose level within 5 seconds.

Similarly , the standard deviation of A (t) can be approxi
mated as :

Furthermore , long detection time will significantly increase 60

measurement errors due to finger movement, light power
drift, device temperature change , etc . Thus , there is a need

0 [A (1)] In101 Vo [A]1(1)]B+ 02[n(t)]

(15 )

for new techniques to measure blood glucose levels quickly
Improving S /N Ratio by Standard Deviation
65 Equation ( 15 ) demonstrates great noise reduction power
The time dependent detector photocurrent output, Io (t), of Equation ( 13 ). For example , for a relatively high baseline

and accurately .

shown in FIG . 1 can be expressed as the sum of a small time

noise with the ratio
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p =

Q :( C , T ) = AA(4;)

o [n (1) ]

o [logAl( ] = 0.1 (or 10% ),

=

o?logId (Ai, )]/k

· =

o?logId (11, 1) ]

(18 )

N

AA( ;) o?log/p( :,1)]/k ? o[loglp (;,1)]

the contribution to o [ A (t) ] from the baseline noise n (t) is
estimated to be less than 0.005 (or 0 .5 % ), corresponding to

As shown by Equation ( 18 ), the constant k is cancelled

an increase in S /N ratio by a factor of 20 without increasing

and o?log Iy (t) ] will be used in further regression analysis to

detection time. As such , dramatic noise reduction can be

establish correlation between the optical measurement and

obtained without increasing the data acquisition time, and a 10 blood glucose level. This is possible because data are taken
finger based pulsatile measurement can be completed within simultaneously from all detection channels .

the time interval of one heartbeat (which is approximately

A correlation between optical measurement and blood

one second ), and the requirement for the S / N ratio of 100 to

glucose concentration can be established according to the

1 in determination of AA can be satisfied using an optical

system with a baseline noise of about 6 .0x10 -4 absorbance

(peak to peak ) within a 10 Hz bandwidth . It should be
is dominated by shot noise due to low light illumination

following Equation :

15

pointed out that when the baseline noise of an optical system

Copicot= Ža:(7)0:0C,1)

power, a noise reduction by a factor of 20 equals an
increasing in light illumination power by a factor of

( 19 )

202 = 400 .

in which Copticai is the blood glucose concentration predicted
by
optical measurement, Q .(CT) is defined by Equations
short data acquisition time, e . g., less than one second, will (17the
)
and
( 18 ), and a ;( T ) is the temperature dependent regres
significantly reduce detection error caused by factors such as
sion coefficient corresponding to wavelength z. The values
finger movement, temperature change, and light power drift 25, of
a ;( T ) can be extracted using proper statistics methods such
This ability of obtaining higher S /N ratio within the very

during the measurement, and therefore dramatically improve
the accuracy and reproducibility of the pulsatile detection

as Partial Least Squares ( PLS ) regression .

Equation ( 19 ) represents ideal cases when large number

methodology

of calibrations can be made at different finger temperatures.

Furthermore , the value of k does not change with wave

In reality, frequently only a limited number of calibrations
length , because transmitted lights at all wavelengths have 30 can
be made ( e .g ., 15 to 20 ), and each may be taken at a
identical pulse shape due to the heartbeat. As a result, the different
finger temperature . Under this condition , the finger
constant k will be cancelled in data normalization discussed
temperature
can be treated as an independent variable , and
in next section , and o [ log ID (t) ] will be used in further

regression analysis to establish correlation between the the above Equation can be approximated as :
optical measurement and blood glucose level. This will 35
os
greatly simplify the data analysis process since o?log I , (t )]

involves only two standard math functions available in most

bili( CAT ) + nT

popular spreadsheet programs such as Microsoft EXCEL® .
EXCEL® is a federally registered trademark of Microsoft

(20)

Corporation , having a place of business at One Microsoft an40 in which b ; is the temperature independent regression coef

Way, Redmond , Wash . 98052 -6399 .

ficient corresponding to wavelength ;, and n is the regres

Normalization

At each wavelength ài, the absorption AA ( ;) is linked to
the increase of amount of blood (AB ) in the optical sensing
area of the fingertip due to the heartbeat by the following
Equation : gerup que lo me heartbeat by the 10110wng 45
(16)

A4(A ) =E( C,2 , T)AB

sion coefficient for the finger temperature . The values of b ;
and that of n can be extracted using proper statistics methods

such asMethodoloov
Partial Least Squares (PLS) regression .
Ratio

Alternatively, the uncertainty from the variable AB can be
cancelled by introducing a ratio factor Y , at wavelength àz:

in which e (C , , T ) is the absorption / scattering coefficient of
blood at wavelength d?, finger temperature T, and blood

_ AA( ;) E(C, 1;, T) _ o [log/p(4;,t)]
(21)
glucose concentration C . It is well understood that the 30
Ha? ! " AA(A ;) – (C , 1 ;, T ) – o [log/p (1 ;, t)]'
variable AB differs from person to person , and may even
change from day to day for the same person .
The uncertainty from the variable AB can be cancelled
by
incelled
by inin which j can be any number from 1 to N , assuming that the
introducing the normalization factor Q :(C , T) at each
wave
wave
55 device collects signal at all N wavelengths .
length ;, as defined by the Equation below :
Similar to the normalization algorithm discussed before ,

a correlation between optical measurement and blood glu

Q :( C , 1 ) =

AAA
AA (1 ;)

( C , 1;, T )

§ 44(1;) Š &(C,1;,1)

SAAN;)

cose level can be established according to the following

( 17 )

Equation :
60

(22)

Coptical = ) fi( 7) Y;;( C , T)
in which N is total number of wavelength employed . Pref
i j
erably, N typically ranges from twenty to thirty .
Based on Equations (13 ) and ( 17 ), Q :(C , T ) is linked to the 65
detector photocurrent at each wavelength ;, 1 ( ;,t ), by the
in which Copticaj is the blood glucose concentration pre
following Equation :
dicted by the optical measurement, Y (CT) is defined by
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Equation (21), and f;( T ) is the temperature dependent regres sion coefficient corresponding to wavelength ?z. The value
of f; ( T ) can be obtained using statistics methods such as
Partial Least Squares (PLS ) regression .

In reality, frequently only limited number of calibration can
be made (e.g ., 15 to 20 ), and each may be taken at a different

FIG . 4 shows the schematic circuit diagram of a typical
preamplifier, which is generally indicated by numeral 400 .
The output voltage 412 of ith preamplifier 400 , in cou
pling with ith photodiode detector 408 , can be expressed as :
Vi(t)= r;15 ( t)= Ro; [1 +%:(Tri(t)- 25° C.)]]] () int)
In the above Equation (27 ), Ro; is the resistance value of
feedback resistor 402 for ith preamplifier at 25° C ., Xi is the

Equation can be approximated as :

both side of the Equation ( 27 ), one obtains:

Equation (22 ) represents ideal cases when large number 5

of calibration can be made at different finger temperatures .

finger temperature . Under this condition , the finger tempera - temperature coefficient of the resistor, and Tri(t ) is the
ture can be treated as an independent variable , and the above 10 temperature of the resistor. Applying common logarithm to
log V:(t)= log R ;o+ log [1 + X:(Tri(t)- 25° C .)]+ log 10 (hi

Copicot = { th:Yj(C,1)+ BT

(23)

ij

1)

(28 )

15 Considering the fact that Roi is a constant and that the
resistor temperature Tri (t) does not change during the very
short data acquisition time interval of approximately one

one obtains.:
widt ,, vivum
in which h ; is the temperature independent regression coef second
ficient corresponding to wavelength ;, and ß is the regres
(29)
O [log V: ( ]= o [log 10 (1 ;,t)]
sion coefficient for the finger temperature . The values of h ; 20 Substituting Equation (26 ) into Equation (29 ), one
and that of ß can be extracted using proper statistics methods
obtains :
such as Partial Least Squares (PLS) regression .
avice
Elimination of the Effect of Temperature Dependent Device
(30)
O [log V;()]=o [log P (),;t)]
Response

It is well understood that the detector sensitivity of a 25 As such , the uncertainty caused by resistor temperature Ty(t )

silicon photodiode detector is a function of wavelength and is eliminated .
Under the voltage detection mode, the normalization
temperature. For the device configuration shown in FIG . 2 ,
which is generally indicated by numeral 200 , the light power factor in Equation (18 ) can be expressed as :
received by ith silicon diode detector, corresponding to
wavelength ;, is converted into a photocurrent according to 30
( 31)
the following Equation :
Qi(C , 1 ) = o [logV;(0)]

Id (),;,t)= P () ,t)S0 (2 )(1+ y(2 )(TD :(t)- 25° C .)]

o [logy:(0)]

(24 )

In the above Equation (24 ), P ( ;,t) is the light power

received by the detector, Sca ) is the photosensitivity of the ~
Themathematic correlation between optical measurement
detector at wavelength ; and 25° C ., y (a ) is the temperature
and blood glucose concentration can then be established

coefficient of the photosensitivity at wavelength ài, and
T ) ; (t ) is the temperature of ith photodiode detector. The
temperature coefficient yaz) varies with the wavelength . For

according to Equation (19 ) or Equation ( 20 ), under corre
Similarly , the ratio factor defined by Equation (21) can be

sponding calibration conditions .

example, for Hamamatsu S1337 series photodiode detectors , to expressed as :
ya; ) ranges from near zero at 900 nm to over 1 . 0 % /° C . at

1100 nm . This imposes a potential problem for the device

configuration show in FIG . 2 , because it is very difficult to
keep temperature of each individual diode detector constant 45

o [logV ;(d)]
Y.;(C , T ) = o?logV
;(r)]

(32)

in a handheld device used by a person with diabetes under

a normal household /office environment.

mathematic correlation between optical measurement
This uncertainty due to the detector temperature Tdi(t) andTheblood
concentration can then be established
can be eliminated using the algorithm shown by Equations according toglucose
Equation
( 22 ) or Equation ( 23 ), under corre
( 12 ) and ( 13 ) . Applying common logarithm on both sides of 50 sponding calibration conditions
. The schematic circuit dia
the Equation (24 ), one obtains:
gram of a typical preamplifier 400 also includes a feedback
capacitor 404 , an operational amplifier 406 , and a ground
log 10 ( t) =log P () ,[)+ log S. ( ;)+ log[1 + y(^;)( TDi
(t) - 25° C .)]

(25)

Considering the fact that S . (^ ;) is a constant and that 55

detector temperature TDi(t) remains almost constant during
the very short data acquisition time interval of approxi

connection 410 .
Digitization

The voltage output 412 from the preamplifier 400 is

usually digitized using an analog -to -digital convertor

( ADC ). The digitized signal is then sent to a computer for

mately one second , one obtains :
data analysis. The output of ith ADC , in communication with
ith preamplifier that is in coupling with ith photodiode 408
O [log Ib ( ; )]= o [log P () ,1)]
(20) 60 collecting light power at wavelength l?, can be expressed by
As such , the uncertainty caused by detector temperature the following Equation :
Toi(t) is eliminated by the use of this standard deviation
( 33)
(ADC) = (ADC )o;+ G ;{[Id () ;t)+ IDark,j]R;+ 40;}
methodology.
Voltage Detection Mode
In the above Equation (33 ), (ADC )o; is the offset of ith
In the device configuration shown in FIG . 2 , the photo - 65 ADC , G ; is the nominalADC Gain used during the detection ,
current of ith photodiode detector ID ;,t) is typically con - ID ;,t) is the photo current of ith photodiode detector, IDarksi
verted into a voltage using a preamplifier before digitization . is the dark current of ith photodiode detector, R = R .;[ 1 + Xi
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( Tri(t) - 25° C .)]] is the resistance of feedback resistor of ith preamplifier, and
Ao; is the offset of ith preamplifier.

by the claims that follow . It should be understood that the
embodiments disclosed herein include any and all combi

The contribution of the three factors, (ADC )oi, IDarki and

nations of features described in any of the dependent claims.
The invention claimed is:

Aoi can be removed by carrying out a dark measurement

with the light source turned off right before or after the 5
1. A system for detecting glucose in a biological sample ,
corresponding finger measurement . When the light source is
comprising:
at least one light beam generating structure generating one
turned off , the above Equation (33 ) becomes :
or more light beams having a wavelength in a range
(34 )
( ADC)Dark,i=(ADC )o:+G ;(IDark,{R + A01 )
between 800 nm and 1600 nm to strike a target area of

The difference between the two above Equations (33) and 10
( 34 ) reflects ADC output corresponding to the photocurrent:
(35)
A (ADC) (ADC) -(ADC)Dark,;=G ;Id ( ,t)R ;
Applying common logarithm to both side of the Equation

(35 ), one obtains :

15
15

log A (ADC);= log G ;+ log Ib (Qvj,t)+ log R ;
(36 )
G ; and R ¡ can be considered as constants as long as the

containing one or more photodiodes positioned to
receive detected blood glucose level information in the

one or more light beams and to transform the detected
blood glucose level information in the one ormore light
beams to the detected blood glucose level information

in an output photocurrent signal, having a time depen

time interval between the finger measurement and the dark
measurement is short. As such , one obtains :
20
O [log A(ADC ):]= o [ log 10 (2 1)]
(37)

Substituting Equation ( 26 ) into Equation (37 ), one further

dent current, which is indicative of the power of light

detected; and

a blood glucose level caused light absorbance change
determining algorithm implemented processor pro
grammed to calculate a change in a light absorption

caused by blood in the biological sample and config
ured to receive the output photocurrent signal from the

obtains :
o [log A ( ADC ):]= o [log P (),1)]

(38) 25
Based on Equation ( 37 ), the normalization factor defined

by Equation ( 18 ) can be expressed as :
Q :(C , T) = o [logA ( ADC); ]

a biological sample ;
at least one photocurrent signal generating light detector

(39) 30

o [logA(ADC);]

at least one light detector and based on the received

output photocurrent signal, calculate attenuance attrib
utable to blood in a sample present in the target area and
eliminate effect of uncertainty caused by temperature
dependent detector response of the at least one light

detector by calculating standard deviation of a loga

rithm of the timedependent output current generated by
the light power from the same target area of the

biological sample , and based on the calculated attenu

ance , determine a blood glucose level associated with

The mathematic correlation between opticalmeasurement 35

and blood glucose concentration can then be established
according to Equation ( 19 ) or ( 20 ), under corresponding
calibration conditions.
Similar to normalization , the ratio factor defined by

Equation (21) can be expressed as:
o [logA (ADC);]

Y;j(C , T ) = o?logA (ADC);]

a sample present in the target area .

2 . The system for detecting glucose in a biological sample
according to claim 1 , wherein the processor is configured to

eliminate the effect of uncertainty caused by temperature of

the at least one light detector by calculating the following

40 equation with the processor: o [log ID ( z,t) ]= o [log Paz,t],
where the ith wavelength being represented by à?, based on

the time dependent detector output current signal I , ( , ) and
the time dependent detector power signal P ( ;,t), where log

(40)

Ida ,t) is the logarithm of the time dependent detector

45 output current signal and log P ( ;,t ) is the logarithm of the

The correlation between optical measurement and blood

time dependent light power received by the corresponding
detector.

Equations (22 ) or ( 23 ), under corresponding calibration

according to claim 1 , wherein the at least one light detector

glucose concentration can then be established according to
conditions.

Thus, there has been shown and described several

embodiments of a novel invention . As is evident from the

foregoing description , certain aspects of the present inven

tion are not limited by the particular details of the examples
illustrated herein , and it is therefore contemplated that other

modifications and applications, or equivalents thereof, will
occur to those skilled in the art. The terms “ have ," " having,”
“ includes,” “ including," and similar terms as used in the
foregoing specification are used in the sense of “ optional or

3 . The system for detecting glucose in a biological sample

50 includes a preamplifier having a feedback resistor.
4 . A method for detecting glucose in a biological sample ,
comprising:
utilizing at least one light beam generating structure to
generate one or more light beams having a wavelength
55
in a range between 800 nm and 1600 nm to strike a
target area of a biological sample ;

" may include” and not as " required .” Many changes , modi- 60
fications , variations and other uses and applications of the

present construction will , however, become apparent to

those skilled in the art after considering the specification and
the accompanying drawings. All such changes , modifica

tions , variations and other uses and applications, which do 65
not depart from the spirit and scope of the invention , are

deemed to be covered by the invention , which is limited only

utilizing at least one photocurrent signal generating light
detector positioned to receive detected blood glucose

level information in the one ormore light beams and to

transform the detected blood glucose level information
in the one or more light beams to the detected blood

glucose level information in an output photocurrent
indicative of power of light detected ;
receiving the output photocurrent signal from the at least
one light detector with a processor and based on the
received output photocurrent signal, wherein the pro
signal, having a time dependent current, which is
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cessor is programmed to implement a blood glucose

level caused light absorbance change determining algo
rithm to calculate a change in a light absorption caused
by blood in the biological sample;

calculating attenuance attributable to blood in a biological 5
sample present in the target area with the processor ;
eliminating effect of uncertainty caused by temperature
dependent detector response of the at least one light

detector with the processor by calculating standard
deviation of a logarithm of the time dependent output 10
current generated by the light power from the same

target area of the biological sample; and
determining a blood glucose level associated with a
biological sample present in the target area based on the
calculated attenuance with the processor.
5 . The method for detecting glucose in a biological
sample according to claim 4 , wherein the step of eliminating

effect of uncertainty caused by temperature dependent detec
tor response of the at least one light detector further includes
calculating the following equation with the processor : o [log 20
1 , ( ;,t) ] = o [log P2 ;,t) ], where the ith wavelength being
represented by die based on the time dependent detector

output current signal Id at
( ) and the time dependent detector

power signal Paz,t), where log ID at
( ) is the logarithm of
Paq,t) is the logarithm of the time dependent light power
received by the corresponding detector.
6 . The method for detecting glucose in a biological
sample according to claim 4 , wherein the step of utilizing at
least one light detector includes utilizing a preamplifier 30
having a feedback resistor.
the time dependent detector output current signal and log 25
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